Kolexia
Bernard Léa Médecine générale
Bernard Léa
Médecine générale
Cabinet libéral
Nordhouse, France
20 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Maladie du greffon contre l'hôte Tumeurs hématologiques Récidive tumorale locale Lymphomes Myélome multiple Lymphome malin non hodgkinien Maladie de Hodgkin Neutropénie fébrile Leucémies

Collaborateurs

Voir plus
Gardès Maxime
Gardès Maxime
Cabinet libéral, Strasbourg, France
Morel Astrid
Morel Astrid
Centre Léon-Bérard, Lyon, France
Margue Magali
Margue Magali
CHU Strasbourg, Strasbourg, France
Bouchard Philippe
Bouchard Philippe
Hôpital Saint-Antoine, Paris, France

Industries

Voir plus
VIRBAC FRANCE
2 collaboration(s)
Dernière en 2022
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
Improved outcomes of UM171-expanded cord blood transplantation compared with other graft sources: real-world evidence.
Blood advances   29 septembre 2023
Bortezomib Maintenance After Allogeneic Transplantation in Newly Diagnosed Myeloma Patients Results in Decreased Incidence and Severity of Chronic GVHD.
Transplantation and cellular therapy   02 novembre 2022
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
Transplantation and cellular therapy   12 octobre 2022
Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Current oncology (Toronto, Ont.)   22 août 2022
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.
Transplantation and cellular therapy   23 décembre 2021
Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study.
Bone marrow transplantation   29 novembre 2021
Newly diagnosed multiple myeloma patients treated with tandem auto-allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only.
Clinical transplantation   22 octobre 2020
UM171-Expanded Cord Blood Transplants Support Robust T Cell Reconstitution with Low Rates of Severe Infections.
Transplantation and cellular therapy   03 octobre 2020
Single UM171-expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors.
European journal of haematology   31 août 2020
Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.
The Lancet. Haematology   06 novembre 2019